HOXB13 and neoplasm: Earlier, we reported that HOXB13 is an epigenetic target of BRD4 in CRPCs, and suppression of HOXB13 expression by the BET inhibitors JQ1 or MA4-class of compounds induces apoptosis and significantly inhibits PC xenograft tumor growth [10,15,39].